Stage IIIA Colorectal Cancer AJCC v8 Recruiting Phase 2 Trials for Regorafenib (DB08896)

Indication	Status	Phase
DBCOND0109857 (Stage IIIA Colorectal Cancer AJCC v8)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03844620	Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer	Treatment	Regorafenib (DB08896) TAS-102 (DB08937) Tipiracil (DB09343) Trifluridine (DB00432)
NCT04117945	Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer	Treatment	Cetuximab (DB00002) Irinotecan (DB00762) Panitumumab (DB01269) Regorafenib (DB08896)